Table 4.
Baseline, intervention and post-intervention lipid concentrations and MP densities for case study participant
| Phase | 15-min MP density | 30-min MP density | 1-deg MP density | 1.75-deg MP density | TC (mmol/L) | HDL (mmol/L) | LDL (mmol/L) | TC:HDL (mmol/L) | LDL:HDL (mmol/L) |
|---|---|---|---|---|---|---|---|---|---|
| AS Baseline | 0.834 | 0.65 | 0.37 | 0.17 | 5.85 ± 0.33 | 1.27 ± 0.12 | 4.15 ± 0.26 | 4.64 | 3.29 |
| AS intervention | 0.843 | 0.59 | 0.35 | 0.07 | 3.86 ± 0.35 | 1.39 ± 0.06 | 2.08 ± 0.45 | 2.8 | 1.50 |
| AS post-intervention | 0.84 | 0.65 | 0.38 | 0.17 | 4.45 ± 0.25 | 1.37 ± 0.10 | 2.65 ± 0.24 | 3.28 | 1.94 |
| Two-year wash-out period | |||||||||
| RS Baseline | 0.956 | 0.728 | 0.408 | 0.17 | 4.71 ± 0.56 | 1.31 ± 0.12 | 2.90 ± 0.69 | 3.62 | 2.25 |
| RS intervention | 1.005 | 0.77 | 0.485 | 0.20 | 3.60 ± 0.31 | 1.43 ± 0.13 | 1.91 ± 0.34 | 2.65 | 1.35 |
| RS post-intervention | 1.06 | 0.72 | 0.51 | 0.26 | 4.95 ± 0.0 | 1.22 ± 0.0 | 3.42 ± 0.0 | 4.1 | 2.80 |
AS = atorvastatin; RS = rosuvastatin
Values expressed as means ± SD
*given the fact that there were no significant differences in MP density during the intervention, only one post-intervention was taken